Literature DB >> 26303573

Suppressed invasive and migratory behaviors of SW1353 chondrosarcoma cells through the regulation of Src, Rac1 GTPase, and MMP13.

Wenxiao Xu1, Qiaoqiao Wan2, Sungsoo Na2, Hiroki Yokota3, Jing-Long Yan4, Kazunori Hamamura5.   

Abstract

Chondrosarcoma is the second frequent type of primary bone cancer. In response to stress to the endoplasmic reticulum, activation of eIF2α-mediated signaling is reported to induce apoptosis. However, its effects on invasive and migratory behaviors of chondrosarcoma have not been understood. Focusing on potential roles of Src kinase, Rac1 GTPase, and MMP13, we investigated eIF2α-driven regulation of SW1353 chondrosarcoma cells. In particular, we employed two chemical agents (salubrinal, Sal; and guanabenz, Gu) that elevate the level of eIF2α phosphorylation. The result revealed that both Sal and Gu reduced invasion and motility of SW1353 chondrosarcoma cells in a dose dependent manner. Live imaging using a fluorescent resonance energy transfer (FRET) technique showed that Sal and Gu downregulated activities of Src kinase as well as Rac1 GTPase in an eIF2α dependent manner. RNA interference experiments supported an eIF2α-mediated regulatory network in the inhibitory role of Sal and Gu. Partial silencing of MMP13 also suppressed malignant phenotypes of SW1353 chondrosarcoma cells. However, MMP13 was not regulated via eIF2α since administration of Sal but not Gu reduced expression of MMP13. In summary, we demonstrate that eIF2α dependent and independent pathways regulate invasion and motility of SW1353 chondrosarcoma cells, and inactivation of Src, Rac1, and MMP13 by Sal could provide a potential adjuvant therapy for combating metastatic chondrosarcoma cells.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chondrosarcoma; MMP13; Rac1; Src; eIF2α

Mesh:

Substances:

Year:  2015        PMID: 26303573     DOI: 10.1016/j.cellsig.2015.08.014

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  14 in total

1.  Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis.

Authors:  Michal Hlavac; Annika Dwucet; Richard Eric Kast; Jens Engelke; Mike-Andrew Westhoff; Markus D Siegelin; Klaus-Michael Debatin; Christian Rainer Wirtz; Marc-Eric Halatsch; Georg Karpel-Massler
Journal:  Cell Oncol (Dordr)       Date:  2019-03-11       Impact factor: 6.730

2.  Salubrinal Suppresses IL-17-Induced Upregulation of MMP-13 and Extracellular Matrix Degradation Through the NF-kB Pathway in Human Nucleus Pulposus Cells.

Authors:  Zhixiao Yao; Lin Nie; Yunpeng Zhao; Yuanqiang Zhang; Yi Liu; Jingkun Li; Lei Cheng
Journal:  Inflammation       Date:  2016-12       Impact factor: 4.092

3.  Reduction in Migratory Phenotype in a Metastasized Breast Cancer Cell Line via Downregulation of S100A4 and GRM3.

Authors:  Andy Chen; Luqi Wang; Bai-Yan Li; Jesse Sherman; Jong E Ryu; Kazunori Hamamura; Yunlong Liu; Harikrishna Nakshatri; Hiroki Yokota
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

4.  Inhibitory Effects of Dopamine Receptor D1 Agonist on Mammary Tumor and Bone Metastasis.

Authors:  Kazumasa Minami; Shengzhi Liu; Yang Liu; Andy Chen; Qiaoqiao Wan; Sungsoo Na; Bai-Yan Li; Nariaki Matsuura; Masahiko Koizumi; Yukun Yin; Liangying Gan; Aihua Xu; Jiliang Li; Harikrishna Nakshatri; Hiroki Yokota
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

5.  Inhibiting checkpoint kinase 1 protects bone from bone resorption by mammary tumor in a mouse model.

Authors:  Shengzhi Liu; Yang Liu; Kazumasa Minami; Andy Chen; Qiaoqiao Wan; Yukun Yin; Liangying Gan; Aihua Xu; Nariaki Matsuura; Masahiko Koizumi; Yunlong Liu; Sungsoo Na; Jiliang Li; Harikrishna Nakshatri; Bai-Yan Li; Hiroki Yokota
Journal:  Oncotarget       Date:  2018-01-19

Review 6.  Emerging Roles of the Endoplasmic Reticulum Associated Unfolded Protein Response in Cancer Cell Migration and Invasion.

Authors:  Celia Maria Limia; Chloé Sauzay; Hery Urra; Claudio Hetz; Eric Chevet; Tony Avril
Journal:  Cancers (Basel)       Date:  2019-05-06       Impact factor: 6.639

Review 7.  The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis.

Authors:  Heinrich Kovar; Lisa Bierbaumer; Branka Radic-Sarikas
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

8.  Loading-induced antitumor capability of murine and human urine.

Authors:  Di Wu; Yao Fan; Shengzhi Liu; Mark D Woollam; Xun Sun; Eiji Murao; Rongrong Zha; Rahul Prakash; Charles Park; Amanda P Siegel; Jing Liu; Mangilal Agarwal; Bai-Yan Li; Hiroki Yokota
Journal:  FASEB J       Date:  2020-04-15       Impact factor: 5.191

9.  Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway.

Authors:  Luqi Wang; Yue Wang; Andy Chen; Meghana Teli; Rika Kondo; Aydin Jalali; Yao Fan; Shengzhi Liu; Xinyu Zhao; Amanda Siegel; Kazumasa Minami; Mangilal Agarwal; Bai-Yan Li; Hiroki Yokota
Journal:  FASEB J       Date:  2019-10-04       Impact factor: 5.834

10.  Mechanical stimulations can inhibit local and remote tumor progression by downregulating WISP1.

Authors:  Shengzhi Liu; Di Wu; Xun Sun; Yao Fan; Rongrong Zha; Aydin Jalali; Meghana Teli; Tomohiko Sano; Amanda Siegel; Akihiro Sudo; Mangilal Agarwal; Alexander Robling; Bai-Yan Li; Hiroki Yokota
Journal:  FASEB J       Date:  2020-08-03       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.